Checking your breasts only takes a few minutes. The sooner breast cancer is found, the more successful treatment is likely to be
Search results
Breast screening uses mammography radiography to detect small changes in the breast before other symptoms or signs of breast cancer develop. If breast cancer is found at an early stage, there is an increased chance of breast-conserving surgery and a better prognosis for long-term survival. The NHS Breast Screening Programme saves around 1300 ...
- Screening Around The UK
- Review Cycle
- Organisations Interested in Breast Cancer
The UK NSC recommends screening for this condition, however this may vary slightly depending on where you are in the UK.
Date previous review completed: 2019 Next review estimated to be completed: 2023 to 2024. To see previous evidence reviews, visit the UK NSC archive.
These organisations have expressed interest in this recommendation and may submit responses to evidence reviews.
The NHS Breast Screening Programme in England was set up in 1988 and provides 3-yearly routine breast screening to women. Breast screening uses mammography radiography to detect small changes in the breast before other symptoms or signs of breast cancer develop. If breast cancer is found at an early stage, there is an increased chance of breast ...
Other risks of breast screening include: a cancer being missed – mammograms do not always find a cancer that is there; X-rays – having a mammogram every 3 years for 20 years gives you a very slightly higher chance of getting cancer over your lifetime; Most people feel the benefits of breast screening outweigh the possible risks.
Sep 27, 2024 · The NICE familial breast cancer guidelines categorise women at increased risk of breast cancer ... Screening with mammography can be safely performed during pregnancy but as mammographic density ...
- This guidance has been revised specifically to clarify the following points: which cohort of women is entitled to very high risk screening followin...
- Referrals into the NHS BSP should be through: a genetics service by a consultant clinical geneticist, genetic counsellor or an appropriately traine...
- The NHS BSP screens women at very high risk of breast cancer due to: a proven germline pathogenic variant in BRCA1, BRCA2, TP53, A-T homozygotes, P...
- A woman is considered to be at very high risk if she has a test result that identifies a germline pathogenic variant in a gene that would confer a...
- The screening test should be as indicated, depending upon a woman’s current age and referral reason. Where MRI is stated, but cannot be tolerated,...
- Short-term recalls (STR) are defined as a further appointment to attend a screening assessment indicated before the normal screening interval (one...
- A woman at VHR should continue to be invited for screening up to her 71st birthday or up to the age of 50 where she is determined to be at an equiv...
- Screening with mammography can be safely performed during pregnancy but as mammographic density increases during pregnancy and lactation, its effec...
- Transgender (trans) men and non-binary people who have breast tissue and fulfil the criteria to be eligible for very high risk screening will be in...
- Technical guidelines on the use of MRI for the surveillance of women at higher risk must be followed. This includes information relating to physics...
Jun 1, 2015 · Added guidance on Partial or incomplete screening mammography. 1 October 2020. ... Added Breast screening: quality assurance guidelines for breast pathology services. 12 August 2020.
People also ask
Who is eligible for breast screening?
Where can I find quality assurance guidelines for breast screening?
Is there evidence for breast cancer screening?
How many breast cancer deaths are prevented by breast cancer screening?
How often should a woman get a breast MRI & Mammography?
Should I go for breast screening?
Jun 18, 2021 · Breast cancer remains the most common nonskin cancer, the second leading cause of cancer deaths, and the leading cause of premature death in US women. Mammography screening has been proven effective in reducing breast cancer deaths in women age 40 years and older. A mortality reduction of 40% is possible with regular screening. Treatment advances cannot overcome the disadvantage of being ...
